130 related articles for article (PubMed ID: 25301484)
1. Transforming growth factor β1 (TGFβ1) and vascular endothelial growth factor (VEGF) in the blood of healthy people and patients with Graves' orbitopathy--a new mechanism of glucocorticoids action?
Kajdaniuk D; Marek B; Niedziołka-Zielonka D; Foltyn W; Nowak M; Siemińska L; Borgiel-Marek H; Głogowska-Szeląg J; Ostrowska Z; Drożdż L; Kos-Kudła B
Endokrynol Pol; 2014; 65(5):348-56. PubMed ID: 25301484
[TBL] [Abstract][Full Text] [Related]
2. Serum concentrations of HGF and IL-8 in patients with active Graves' orbitopathy before and after methylprednisolone therapy.
Nowak M; Siemińska L; Karpe J; Marek B; Kos-Kudła B; Kajdaniuk D
J Endocrinol Invest; 2016 Jan; 39(1):63-72. PubMed ID: 26062519
[TBL] [Abstract][Full Text] [Related]
3. Increased serum VEGF and b-FGF in Graves' ophthalmopathy.
Ye X; Liu J; Wang Y; Bin L; Wang J
Graefes Arch Clin Exp Ophthalmol; 2014 Oct; 252(10):1639-44. PubMed ID: 24867311
[TBL] [Abstract][Full Text] [Related]
4. Serum interleukin-16 and RANTES during treatment of Graves' orbitopathy with corticosteroids and teleradiotherapy.
Mysliwiec J; Palyga I; Nikolajuk A; Kowalska A; Gorska M
Endokrynol Pol; 2012; 63(2):92-6. PubMed ID: 22538746
[TBL] [Abstract][Full Text] [Related]
5. Serum concentration of VEGF and PDGF-AA in patients with active thyroid orbitopathy before and after immunosuppressive therapy.
Nowak M; Marek B; Karpe J; Kos-Kudla B; Sieminska L; Kajdaniuk D; Treszer M
Exp Clin Endocrinol Diabetes; 2014 Nov; 122(10):582-6. PubMed ID: 25140996
[TBL] [Abstract][Full Text] [Related]
6. Serum gelatinases (MMP-2 and MMP-9) and VCAM-1 as a guideline in a therapeutic approach in Graves' ophthalmopathy.
Myśliwiec J; Adamczyk M; Pawłowski P; Nikołajuk A; Górska M
Endokrynol Pol; 2007; 58(2):105-9. PubMed ID: 17578825
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 18 and transforming growth factor beta1 in the serum of patients with Graves' ophthalmopathy treated with corticosteroids.
Myśliwiec J; Kretowski A; Stepień A; Mirończuk K; Kinalska I
Int Immunopharmacol; 2003 Apr; 3(4):549-52. PubMed ID: 12689659
[TBL] [Abstract][Full Text] [Related]
8. Serum BAFF concentrations in patients with Graves' disease and orbitopathy before and after immunosuppressive therapy.
Vannucchi G; Covelli D; Currò N; Dazzi D; Maffini A; Campi I; Bonara P; Guastella C; Pignataro L; Ratiglia R; Beck-Peccoz P; Salvi M
J Clin Endocrinol Metab; 2012 May; 97(5):E755-9. PubMed ID: 22399512
[TBL] [Abstract][Full Text] [Related]
9. Circulating CXCL9 and CXCL10 as markers of activity of Graves' orbitopathy during treatment with corticosteroids and teleradiotherapy.
Mysliwiec J; Palyga I; Kosciuszko M; Kowalska A; Gorska M
Horm Metab Res; 2012 Dec; 44(13):957-61. PubMed ID: 22752955
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD40 and its ligand CD154 in patients with Graves' ophthalmopathy during combined therapy with corticosteroids and teleradiotherapy.
Myśliwiec J; Waligórski D; Nikołajuk A; Górska M
Adv Med Sci; 2007; 52():104-8. PubMed ID: 18217399
[TBL] [Abstract][Full Text] [Related]
11. Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy.
Woo YJ; Jang SY; Lim TH; Yoon JS
Korean J Ophthalmol; 2015 Aug; 29(4):213-9. PubMed ID: 26240504
[TBL] [Abstract][Full Text] [Related]
12. Serum pro- and anti-inflammatory cytokines in patients with Graves' disease with ophthalmopathy during treatment with glucocorticoids.
Myśliwiec J; Kretowski A; Szelachowska M; Mikita A; Kinalska I
Rocz Akad Med Bialymst; 1999; 44():160-9. PubMed ID: 10697431
[TBL] [Abstract][Full Text] [Related]
13. CD8+CD28-lymphocytes in peripheral blood and serum concentrations of soluble interleukin 6 receptor are increased in patients with Graves' orbitopathy and correlate with disease activity.
Slowik M; Urbaniak-Kujda D; Bohdanowicz-Pawlak A; Kapelko-Slowik K; Dybko J; Wolowiec D; Jazwiec B; Daroszewski J
Endocr Res; 2012; 37(2):89-95. PubMed ID: 22489922
[TBL] [Abstract][Full Text] [Related]
14. Blood Pressure Profile and N-Terminal-proBNP Dynamics in Response to Intravenous Methylprednisolone Pulse Therapy of Severe Graves' Orbitopathy.
Miskiewicz P; Milczarek-Banach J; Bednarczuk T; Opolski G; Glowczynska R
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30261581
[TBL] [Abstract][Full Text] [Related]
15. Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids.
Myśliwiec J; Kretowski A; Topolska J; Siewko K; Jakubczyk D; Szelachowska M; Mikita A; Kinalska I
Horm Metab Res; 2001 Dec; 33(12):739-43. PubMed ID: 11753760
[TBL] [Abstract][Full Text] [Related]
16. Serum CYR61 Is Associated with Disease Activity in Graves' Orbitopathy.
Woo YJ; Seo Y; Kim JJ; Kim JW; Park Y; Yoon JS
Ocul Immunol Inflamm; 2018; 26(7):1094-1100. PubMed ID: 28548552
[TBL] [Abstract][Full Text] [Related]
17. The therapeutic outcome to intravenous steroid therapy for active Graves' orbitopathy is influenced by the time of response but not polymorphisms of the glucocorticoid receptor.
Vannucchi G; Covelli D; Campi I; Origo D; Currò N; Cirello V; Dazzi D; Beck-Peccoz P; Salvi M
Eur J Endocrinol; 2014 Jan; 170(1):55-61. PubMed ID: 24128430
[TBL] [Abstract][Full Text] [Related]
18. Acute liver damage following intravenous glucocorticoid treatment for Graves' ophthalmopathy.
Moleti M; Giuffrida G; Sturniolo G; Squadrito G; Campennì A; Morelli S; Puxeddu E; Sisti E; Trimarchi F; Vermiglio F; Marinò M
Endocrine; 2016 Oct; 54(1):259-268. PubMed ID: 27003434
[TBL] [Abstract][Full Text] [Related]
19. Serum Cystatin C Concentrations in Patients with Graves' Ophthalmopathy.
Can N; Ozsoy E; Kobat SG; Yusufoglu E; Ilhan N; Demir T
Korean J Ophthalmol; 2020 Oct; 34(5):398-403. PubMed ID: 33099562
[TBL] [Abstract][Full Text] [Related]
20. The effect of methylprednisolone pulse treatment on cytokine network in Graves ophthalmopathy.
Lacka K; Manuszewska E; Korczowska I; Lacki JK
Curr Eye Res; 2007 Mar; 32(3):291-7. PubMed ID: 17453949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
